PharmaCielo Ltd.
PCLOF
$0.02
$0.00-3.31%
OTC PK
| 09/30/2025 | 06/30/2025 | 09/30/2024 | 09/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -- | -- | -8.51% | -8.51% | 2.42% |
| Total Depreciation and Amortization | -- | -- | 204.85% | 314.66% | 88.68% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -- | -- | 19.78% | 15.84% | 3.45% |
| Change in Net Operating Assets | -- | -- | 1,150.24% | 1,150.24% | 218.45% |
| Cash from Operations | -- | -- | 43.94% | 43.94% | 40.54% |
| Capital Expenditure | -- | -- | 92.70% | 92.70% | 99.35% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -83.52% | -83.52% | 21.59% |
| Cash from Investing | -- | -- | -82.30% | -82.30% | 169.84% |
| Total Debt Issued | -- | -- | -42.59% | -30.93% | -36.68% |
| Total Debt Repaid | -- | -- | -19.44% | -19.44% | -47.52% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | 492.50% | 492.50% | 492.50% |
| Cash from Financing | -- | -- | -34.79% | -34.79% | -42.05% |
| Foreign Exchange rate Adjustments | -- | -- | 149.02% | 148.37% | 163.64% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -- | -- | 100.74% | 100.74% | 71.39% |